ILMN

$235.9918.64%-54.07

시간 외 거래: 236.54+0.55 +0.23%

Illumina Inc (ILMN)

Date: O: H: L: C: Vol:

전일 마감가:

$290.06

열려 있는:

$255.77

하루 거래량:

5,385,149

상대 거래량:

2.45

시가총액:

$35.63B

수익:

$4.39B

순이익/손실:

$853.00M

주가수익비율:

42.83

EPS:

$5.51

순현금흐름:

$556.00M

1W 성능:

-12.41%

1M 성능:

-13.77%

6M 성능:

+86.20%

1Y 성능:

+138.35%

1일 변동 폭

$231.18$256.09

1주일 범위

$231.18$294.21

52주 변동 폭

$94.00$309.35

Illumina Inc 주식 (ILMN) 회사 개요

명칭

Illumina Inc

부문

Healthcare

산업

Diagnostics & Research

전화

(858) 202-4500

주소

5200 ILLUMINA WAY, SAN DIEGO, CA, USA

직원

8,600

@illumina

다음 수익 날짜

null

최신 SEC 제출 서류

SEC

X에서 ILMN에 대한 토론

ILMN vs TMO, DHR, NTRA, A, WAT 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
ILMN Illumina Inc	$235.99	$35.63B	$4.39B	$853.00M	$556.00M	$5.51
TMO Thermo Fisher Scientific Inc	$697.00	$257.71B	$45.20B	$6.87B	$6.75B	$18.19
DHR Danaher Corp	$232.23	$163.25B	$24.78B	$3.68B	$5.29B	$5.17
NTRA Natera Inc	$414.30	$59.72B	$2.50B	-$226.32M	$71.51M	-$1.64
A Agilent Technologies Inc	$174.87	$49.30B	$7.23B	$1.41B	$1.09B	$4.98
WAT Waters Corp	$462.72	$45.46B	$3.77B	$449.25M	$240.68M	$7.86

Illumina Inc 주식(ILMN) 업그레이드 및 다운그레이드

날짜	액션	분석자	등급 변경
2026-10-23	다운그레이드	Stephens	Overweight → Equal-Weight
2026-09-09	Resumed	UBS	Buy
2026-06-26	Resumed	Bernstein	Mkt Perform
2026-06-10	업그레이드	JP Morgan	Neutral → Overweight
2026-05-15	Resumed	RBC Capital Mkts	Outperform
2026-05-14	업그레이드	Daiwa Securities	Neutral → Outperform
2025-08-12	다운그레이드	Daiwa Securities	Outperform → Neutral
2025-07-11	다운그레이드	Scotiabank	Sector Outperform → Sector Perform
2025-03-04	재확인	Citigroup	Neutral
2025-02-28	다운그레이드	HSBC Securities	Buy → Hold
2025-02-10	다운그레이드	Barclays	Equal Weight → Underweight
2025-02-07	다운그레이드	TD Cowen	Buy → Hold
2024-12-11	다운그레이드	Citigroup	Buy → Neutral
2024-11-12	Resumed	Morgan Stanley	Equal-Weight
2024-10-17	업그레이드	HSBC Securities	Hold → Buy
2024-08-28	업그레이드	Argus	Hold → Buy
2024-08-16	업그레이드	Daiwa Securities	Neutral → Buy
2024-08-14	업그레이드	Barclays	Underweight → Equal Weight
2024-08-14	업그레이드	TD Cowen	Hold → Buy
2024-07-10	업그레이드	Citigroup	Neutral → Buy
2024-06-03	Resumed	Jefferies	Hold
2024-01-16	다운그레이드	HSBC Securities	Buy → Hold
2024-01-04	다운그레이드	TD Cowen	Outperform → Market Perform
2023-12-18	업그레이드	Scotiabank	Sector Perform → Sector Outperform
2023-12-15	업그레이드	Bernstein	Underperform → Mkt Perform
2023-12-14	개시	Guggenheim	Buy
2023-12-14	개시	Stephens	Overweight
2023-12-13	개시	Wolfe Research	Outperform
2023-12-12	다운그레이드	BofA Securities	Neutral → Underperform
2023-12-11	업그레이드	Citigroup	Sell → Neutral
2023-11-10	다운그레이드	Canaccord Genuity	Buy → Hold
2023-09-28	개시	Bernstein	Underperform
2023-07-05	Resumed	JP Morgan	Neutral
2023-01-25	다운그레이드	Argus	Buy → Hold
2023-01-05	개시	Scotiabank	Sector Perform
2022-12-12	다운그레이드	Citigroup	Neutral → Sell
2022-12-07	개시	RBC Capital Mkts	Outperform
2022-10-04	업그레이드	SVB Leerink	Mkt Perform → Outperform
2022-09-28	업그레이드	Evercore ISI	In-line → Outperform
2022-08-25	개시	Credit Suisse	Neutral
2022-07-13	다운그레이드	Barclays	Equal Weight → Underweight
2022-01-18	업그레이드	Stifel	Hold → Buy
2022-01-11	업그레이드	Barclays	Underweight → Equal Weight
2022-01-07	업그레이드	BofA Securities	Underperform → Neutral
2022-01-06	Resumed	Morgan Stanley	Equal-Weight
2022-01-06	Resumed	Piper Sandler	Overweight
2021-10-15	Resumed	Cowen	Outperform
2021-08-19	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2021-06-01	업그레이드	Evercore ISI	Underperform → In-line
2021-03-31	다운그레이드	Atlantic Equities	Overweight → Neutral
2021-03-31	업그레이드	Canaccord Genuity	Hold → Buy
2021-03-03	개시	Barclays	Underweight
2020-12-22	업그레이드	Piper Sandler	Neutral → Overweight
2020-12-17	업그레이드	BTIG Research	Neutral → Buy
2020-10-13	다운그레이드	Guggenheim	Buy → Neutral
2020-09-30	개시	Atlantic Equities	Overweight
2020-09-29	다운그레이드	Wolfe Research	Outperform → Peer Perform
2020-09-22	다운그레이드	Stifel	Buy → Hold
2020-09-22	다운그레이드	UBS	Buy → Neutral
2020-09-21	업그레이드	Guggenheim	Neutral → Buy
2020-09-21	다운그레이드	JP Morgan	Overweight → Neutral
2020-09-09	개시	Morgan Stanley	Equal-Weight
2020-08-07	다운그레이드	Evercore ISI	In-line → Underperform
2020-08-07	다운그레이드	Piper Sandler	Overweight → Neutral
2020-07-07	다운그레이드	Guggenheim	Buy → Neutral
2020-04-24	다운그레이드	Citigroup	Buy → Neutral
2020-04-21	다운그레이드	Robert W. Baird	Outperform → Neutral
2020-01-08	개시	Wells Fargo	Underweight
2020-01-07	개시	Citigroup	Buy
2020-01-02	다운그레이드	Evercore ISI	Outperform → In-line
2019-11-15	개시	Stifel	Buy
2019-10-25	개시	Guggenheim	Buy

Illumina Inc (ILMN) 재무 분석

매출

순이익

현금흐름

주당 순 이익

Illumina Inc 주식 (ILMN) 내부자 거래

Corvex Management LPSep 04 '26
Affiliate of Director (1)
거래
Proposed Sale
비용
$213.25
#주식
150,000
가치 ($)
31,987,500
#주식 총계
0
Meister Keith A.Sep 03 '26
Director
거래
Sale
비용
$218.23
#주식
75,951
가치 ($)
16,574,481
#주식 총계
889,851
Meister Keith A.Sep 02 '26
Director
거래
Sale
비용
$213.28
#주식
68,108
가치 ($)
14,526,254
#주식 총계
965,802
Corvex Management LPAug 27 '26
Affiliate of Director (1)
거래
Proposed Sale
비용
$224.84
#주식
200,000
가치 ($)
44,968,000
#주식 총계
0
Meister Keith A.Aug 27 '26
Director
거래
Sale
비용
$228.89
#주식
138,379
가치 ($)
31,673,778
#주식 총계
1,033,910
Meister Keith A.Aug 26 '26
Director
거래
Sale
비용
$225.46
#주식
106,543
가치 ($)
24,021,247
#주식 총계
1,172,289
Corvex Management LPAug 25 '26
Affiliate of Director (1)
거래
Proposed Sale
비용
$223.22
#주식
300,000
가치 ($)
66,966,000
#주식 총계
0
Meister Keith A.Aug 25 '26
Director
거래
Sale
비용
$225.51
#주식
131,019
가치 ($)
29,546,639
#주식 총계
1,278,832
Meister Keith A.Aug 21 '26
Director
거래
Sale
비용
$217.96
#주식
299,336
가치 ($)
65,243,445
#주식 총계
1,409,851
Corvex Management LPAug 21 '26
Affiliate of Director (1)
거래
Proposed Sale
비용
$213.24
#주식
250,000
가치 ($)
53,310,000
#주식 총계
0

내부자 거래	관계	날짜	거래	비용	#주식	가치 ($)	#주식 총계
Corvex Management LP	Affiliate of Director (1)	Sep 04 '26	Proposed Sale	$213.25	150,000	31,987,500	0
Meister Keith A.	Director	Sep 03 '26	Sale	$218.23	75,951	16,574,481	889,851
Meister Keith A.	Director	Sep 02 '26	Sale	$213.28	68,108	14,526,254	965,802
Corvex Management LP	Affiliate of Director (1)	Aug 27 '26	Proposed Sale	$224.84	200,000	44,968,000	0
Meister Keith A.	Director	Aug 27 '26	Sale	$228.89	138,379	31,673,778	1,033,910
Meister Keith A.	Director	Aug 26 '26	Sale	$225.46	106,543	24,021,247	1,172,289
Corvex Management LP	Affiliate of Director (1)	Aug 25 '26	Proposed Sale	$223.22	300,000	66,966,000	0
Meister Keith A.	Director	Aug 25 '26	Sale	$225.51	131,019	29,546,639	1,278,832
Meister Keith A.	Director	Aug 21 '26	Sale	$217.96	299,336	65,243,445	1,409,851
Corvex Management LP	Affiliate of Director (1)	Aug 21 '26	Proposed Sale	$213.24	250,000	53,310,000	0

Illumina Inc 주식(ILMN)의 최신 뉴스

Oct 30, 2026

ILMN Q3 Earnings Call Highlights Higher Guidance and Clinical Growth - Zacks Investment Research

Oct 30, 2026

Why is Illumina stock tumbling today? - Investing.com

Oct 30, 2026

Oct 29, 2026

Illumina, Inc. (ILMN) Stock Forecasts - Yahoo Finance

Oct 29, 2026

Illumina (ILMN) Reports Q3 Earnings: What Key Metrics Have to Say - Zacks Investment Research

Oct 29, 2026

Illumina Inc reports results for the quarter ended September 30 - Earnings Summary - TradingView

Oct 29, 2026

Illumina, Inc. (ILMN) Seasonal returns chart - Yahoo Finance Singapore

Oct 29, 2026

Transcript : Illumina, Inc., Q3 2026 Earnings Call, Oct 29, 2026 - www.marketscreener.com

Oct 29, 2026

Illumina Q3 Earnings Call Highlights - Yahoo Finance

Oct 29, 2026

Illumina, Inc. (ILMN) Seasonal Returns Chart - Yahoo Finance - Yahoo! Finance Canada

Oct 29, 2026

Illumina, Inc. (ILMN) Seasonal returns chart - Yahoo Finance UK

Oct 29, 2026

Illumina Inc Reports Q3 2026 Earnings: GAAP EPS of $1.43 Surpasses Estimates, Revenue Hits $1.13 Billion - GuruFocus

Oct 29, 2026

Illumina Q3 2026 Earnings Call Transcript - Benzinga

Oct 29, 2026

Illumina falls despite boosting full-year profit, revenue guidance - Seeking Alpha

Oct 29, 2026

Illumina, Inc. Provides Earnings Guidance for the Fiscal Year 2026 - www.marketscreener.com

Oct 29, 2026

Illumina (ILMN) Q3 Earnings Beat Estimates - Yahoo Finance

Oct 29, 2026

ILLUMINA INC. R (ILU.DE) Q3 FY2026 earnings call transcript - Yahoo Finance

Oct 29, 2026

Earnings Flash (ILMN) Illumina, Inc. Reports Q3 Revenue $1.13B, vs. FactSet Est of $1.15B - www.marketscreener.com

Oct 29, 2026

Illumina (NASDAQ:ILMN) reports sales below analyst estimates in Q3 2026 earnings, stock drops 16% - Yahoo Finance

Oct 29, 2026

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2026 - Illumina

Oct 29, 2026

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2026 - Yahoo Finance

Oct 29, 2026

Oct 28, 2026

Thailand Next Generation Sequencing (NGS) Market Size, Share, Trends, and Forecast - 2026 to 2036 | Precision Medicine Drives 12.7% CAGR and a $305.21 Million Opportunity - GlobeNewswire Inc.

Oct 28, 2026

Oct 27, 2026

Which Biotech ETF Is the Better Buy: VanEck’s BBH or Invesco’s Factor-Driven PBE? - The Motley Fool

Oct 27, 2026

Oct 26, 2026

Billionaire Investor Adds to Danaher Stake After Cutting It Earlier This Year - TradingView

Oct 26, 2026

Oct 25, 2026

VanEck Biotech vs. Invesco Healthcare: Which ETF Offers More Potential for Long-Term Growth? - The Motley Fool

Oct 25, 2026

Oct 24, 2026

Illumina downgraded by Stephens with a new price target - Quantisnow

Oct 24, 2026

Oct 23, 2026

Should Illumina Stock Holders Look At Thermo Fisher Instead? - Trefis

Oct 23, 2026

Here’s How Much You Would Have Made Owning Illumina Stock In The Last 20 Years - Benzinga

Oct 23, 2026

Illumina, Inc. Estimates – NASDAQ:ILMN - TradingView

Oct 23, 2026

Oct 22, 2026

Illumina stock may move 9.3% on earnings release - Investing.com

Oct 22, 2026

Illumina: NovaSeq X And Consumables Sustain Momentum (NASDAQ:ILMN) - Seeking Alpha

Oct 22, 2026

Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth - Zacks Investment Research

Oct 22, 2026

Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

Oct 22, 2026

ILMN Q3 Earnings Preview: Strong Clinical Demand May Lift Performance - TradingView

Oct 22, 2026

Oct 21, 2026

Illumina's Stock Has Run Ahead Of Its Q3 Step-Down, Raising The Stakes On Clinical Demand - Finviz

Oct 21, 2026

Illumina Jumps 5.4% Amid Sector-Wide Rally - AlphaStreet

Oct 21, 2026

Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 21, 2026

Illumina’s (ILMN) Strong Quarterly Beats on Revenue and Earnings Drive Share Gains - Yahoo Finance

Oct 21, 2026

Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discovery - Illumina

Oct 21, 2026

Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discovery - PR Newswire

Oct 21, 2026

Illumina, Inc. (ILMN) Launches Early-Access AI Genomics Tools - TradingView

Oct 21, 2026

Oct 20, 2026

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises - Zacks Investment Research

Oct 20, 2026

Single Cell Sequencing Market Forecast to 2035: Services, Technologies, End-users, Applications, and Regions | 15% CAGR Drives Drug Discovery and Precision Medicine Growth - GlobeNewswire Inc.

Oct 20, 2026

Oct 16, 2026

Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Oct 16, 2026

Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - Zacks Investment Research

Oct 16, 2026

In Brief This Week: Illumina, Interpace, Ocugen, Roots, Elicera, Verily, Quantum-Si, More - GenomeWeb

Oct 16, 2026

Oct 15, 2026

Illumina, Inc. (ILMN) Options Chain - Yahoo! Finance Canada

Oct 15, 2026

Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Oct 15, 2026

TD Cowen lifts target for Illumina stock to USD 270.00 - ad-hoc-news.de

Oct 15, 2026

Saudi Arabia Non-Invasive Prenatal Testing Market 2026-2034: Executive Report | NGS Adoption and Healthcare Investment Drive 13.35% CAGR Toward US$162.16 Million - GlobeNewswire Inc.

Oct 15, 2026

Oct 14, 2026

$100 Invested In Illumina 15 Years Ago Would Be Worth This Much Today - Benzinga

Oct 14, 2026

ILMN와(과) 유사한 종목